409 related articles for article (PubMed ID: 27523412)
1. [Prostate cancer brachytherapy].
Pommier P; Guérif S; Peiffert D; Créhange G; Hannoun-Lévi JM; de Crevoisier R
Cancer Radiother; 2016 Sep; 20 Suppl():S210-5. PubMed ID: 27523412
[TBL] [Abstract][Full Text] [Related]
2. [Prostate cancer external beam radiotherapy].
de Crevoisier R; Pommier P; Latorzeff I; Chapet O; Chauvet B; Hennequin C
Cancer Radiother; 2016 Sep; 20 Suppl():S200-9. PubMed ID: 27516051
[TBL] [Abstract][Full Text] [Related]
3. [High dose rate prostate brachytherapy].
Nickers P; Blanchard P; Hannoun-Lévi JM; Bossi A; Chapet O; Guérif S
Cancer Radiother; 2013 Apr; 17(2):118-24. PubMed ID: 23578898
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer brachytherapy: SFRO guidelines 2021.
Pommier P; Ferré M; Blanchard P; Martin É; Peiffert D; Robin S; Hannoun-Lévi JM; Marchesi V; Cosset JM
Cancer Radiother; 2022; 26(1-2):344-355. PubMed ID: 34955422
[TBL] [Abstract][Full Text] [Related]
5. The role of brachytherapy in the definitive management of prostate cancer.
Crook J
Cancer Radiother; 2011 Jun; 15(3):230-7. PubMed ID: 21514199
[TBL] [Abstract][Full Text] [Related]
6. [Quality of life after radiotherapy for prostate cancer].
Joly F; Degrendel AC; Guizard AV
Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
[TBL] [Abstract][Full Text] [Related]
7. [Prostate cancer: doses and volumes of radiotherapy].
Hennequin C; Rivera S; Quero L; Latorzeff I
Cancer Radiother; 2010 Oct; 14(6-7):474-8. PubMed ID: 20728390
[TBL] [Abstract][Full Text] [Related]
8. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
[TBL] [Abstract][Full Text] [Related]
9. [Radiotherapy of adult soft tissue sarcoma].
Le Péchoux C; Moureau-Zabotto L; Llacer C; Ducassou A; Sargos P; Sunyach MP; Thariat J
Cancer Radiother; 2016 Sep; 20 Suppl():S235-43. PubMed ID: 27523415
[TBL] [Abstract][Full Text] [Related]
10. [Results of 125-iodine seed implant with preplanning system in 250 patients with prostate cancer].
Guinot JL; Ricós JV; Gimeno J; Tortajada MI; Carrascosa M; Santos M; Casanova J; Soler P; Crispín V; Arribas L
Actas Urol Esp; 2011 Jun; 35(6):339-44. PubMed ID: 21481974
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy for anal canal cancers].
Peiffert D; Créhange G; Vendrely V; Baumann AS; Faivre JC; Huger S
Cancer Radiother; 2016 Sep; 20 Suppl():S183-8. PubMed ID: 27523411
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy for clinically localized prostate cancer: optimal patient selection.
Kollmeier MA; Zelefsky MJ
Arch Esp Urol; 2011 Oct; 64(8):847-57. PubMed ID: 22052766
[TBL] [Abstract][Full Text] [Related]
13. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
Mabjeesh NJ; Chen J; Stenger A; Matzkin H
Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
Lawton CA; Yan Y; Lee WR; Gillin M; Firat S; Baikadi M; Crook J; Kuettel M; Morton G; Sandler H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e795-801. PubMed ID: 22330999
[TBL] [Abstract][Full Text] [Related]
16. [Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience].
Zebentout O; Apardian R; Beaulieu L; Harel F; Martin AG; Vigneault E
Cancer Radiother; 2010 Jun; 14(3):183-8. PubMed ID: 20418145
[TBL] [Abstract][Full Text] [Related]
17. Serial changes of international prostate symptom score following I-125 prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T
Int J Clin Oncol; 2006 Aug; 11(4):320-5. PubMed ID: 16937307
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy of cervix and endometrial carcinoma].
Barillot I; Haie-Méder C; Charra Brunaud C; Peignaux K; Kerr C; Thomas L
Cancer Radiother; 2016 Sep; 20 Suppl():S189-95. PubMed ID: 27523423
[TBL] [Abstract][Full Text] [Related]
19. Minimizing prostate brachytherapy-related morbidity.
Merrick GS; Wallner KE; Butler WM
Urology; 2003 Nov; 62(5):786-92. PubMed ID: 14624895
[No Abstract] [Full Text] [Related]
20. [Which modality for prostate brachytherapy?].
Bossi A
Cancer Radiother; 2010 Oct; 14(6-7):488-92. PubMed ID: 20724190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
